Ninety percent of paralyzed patients regained strength or function in their upper limbs after receiving an experimental therapy, a new study found. After receiving spinal cord simulation from ONWARD ...
Saluda Medical Pty Ltd. announced a AU$231 million ($152.7 million) initial public offering on the Australian Securities Exchange to scale up its U.S. footprint for its Evoke spinal cord simulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results